System for use in treatment of vertebral fractures

Abstract
Methods and devices that displace bone or other hard tissue to create a cavity in the tissue. Where such methods and devices rely on a driving mechanism for providing moving of the device to form a profile that improves displacement of the tissue. These methods and devices also allow for creating a path or cavity in bone for insertion of bone cement or other filler to treat a fracture or other condition in the bone. The features relating to the methods and devices described herein can be applied in any region of bone or hard tissue where the tissue or bone is displaced to define a bore or cavity instead of being extracted from the body such as during a drilling or ablation procedure.
Description
FIELD OF THE INVENTION

This invention relates to medical instruments and systems for creating a path or cavity in vertebral bone to receive bone cement to treat a vertebral compression fracture. The features relating to the methods and devices described herein can be applied in any region of bone or hard tissue where the tissue or bone is displaced to define a bore or cavity instead of being extracted from the body such as during a drilling or ablation procedure. In addition, the present invention also discloses methods and devices for ablating or coagulating tissues, including but not limited to ablating tumor tissue in vertebral and/or cortical bone.


SUMMARY OF THE INVENTION

Methods and devices described herein relate to improved creation of a cavity within bone or other hard tissue where the cavity is created by displacement of the tissue. In a first example, a method according to the present disclosure includes treating a vertebral body or other bone structure. In one variation, the method includes providing an elongate tool having a sharp tip configured for penetration into vertebral bone, the tool having an axis extending from a proximal end to a working end thereof, where the working end comprises at least a first sleeve concentrically located within a second sleeve and a third sleeve located concentrically about the second sleeve, where each sleeve comprises a series of slots or notches to limit deflection of the working end to a first curved configuration in a single plane and where the respective series of slots or notches are radially offset in each sleeve; advancing the working end through vertebral bone; causing the working end to move from a linear configuration to a curved configuration by translating the first sleeve relative to the second sleeve in an axial direction; and moving the working end in the curved configuration within the bone to create a cavity therein. Translating of the first sleeve relative to the second sleeve can include moving either sleeve or both sleeves in an axial direction. Additional variations include moving one or both sleeves in a rotational direction to produce relative axial displacement between sleeves.


In an additional variation, the present devices include medical osteotome devices that can for treat a hard tissue (e.g., in a vertebral body) by mechanically displacing the hard tissue and/or applying therapeutic energy to ablate or coagulate tissue. For example, one such variation includes an osteotome type device that is coupled to a power supply and further includes a handle having an actuating portion and a connector for electrically coupling the osteotome device to the power supply; a shaft comprising a first sleeve located concentrically within a second sleeve, the shaft having a distal portion comprising a working end capable of moving between a linear configuration and an articulated configuration where the articulated configuration is limited to a single plane, and where each sleeve comprises a series of slots or notches to limit deflection of the working end to the articulated configuration, where the respective series of slots or notches are radially offset in adjacent sleeves, where a first conductive portion of the shaft is electrically coupleable to a first pole of the power supply; a sharp tip located at a distal tip of the first sleeve of the working end, the sharp tip adapted to penetrate bone within the vertebral body, where the distal tip is coupleable to a second pole of the power supply, such that when activated, current flows between a portion of the distal tip and the shaft; a non-conductive layer electrically isolating the first sleeve from the first conductive portion; and where the shaft and sharp tip have sufficient column strength such that application of an impact force on the handle causes the distal portion of the shaft and the distal tip to mechanically displace the hard tissue. The power supply can be coupled to the outer sleeve (either the second or third sleeve discussed herein.)


Another variations of the method disclosed herein can include the application of energy between electrodes on the device to ablate tissues (e.g., tumor) or to perform other electrosurgical or mapping procedures within the tissue. In one such example for treating a vertebral body, the method can include providing an elongate tool having a sharp tip configured for penetration into vertebral bone, the tool having an axis extending from a proximal end to a working end thereof, where the working end comprises at least a first sleeve concentrically located within a second sleeve, where each sleeve comprises a series of slots or notches to limit deflection of the working end to a first curved configuration in a single plane and where the respective series of slots or notches are radially offset in adjacent sleeves, where a first conductive portion of the first sleeve is electrically coupled to a first pole of a power supply; advancing the working end through vertebral bone; causing the working end to move from a linear configuration to a curved configuration by translating the first sleeve relative to the second sleeve in an axial direction; and applying energy between the first conductive portion and a return electrode electrically coupled to a second pole of the energy supply to ablate or coagulate a region within the vertebral body.


In variations of the method, moving the working end to from the linear configuration to the curved configuration can include moving the working end to move through a plurality of curved configurations.


In an additional variation, causing the working end to move from a linear configuration to the curved configuration comprises actuating a handle mechanism to move the working end from the linear configuration to the curved configuration. The handle mechanism can be moved axially and/or rotationally as described herein.


In one variation, actuating of the handle mechanism causes the working end to move to the first curved configuration without torquing the third sleeve.


In additional variations, the working end of the osteotome or tool is spring biased to assume the linear configuration.


The working end can move from the linear configuration to the curved configuration by applying a driving force or impact to the elongate tool wherein penetration in the cortical bone moves the working end from the linear configuration to the curved configuration. For example, as a hammering or impact force is applied to the working end, the interaction of the sharp tip against bone causes the working end to assume an articulated and/or curved configuration. Where further axial movement of the tool causes compression of the bone and creation of the cavity.


The method can further include the use of one or more cannulae to introduce the tool into the target region. Such a cannula can maintain the tool in a straight or linear configuration until the tool advances out of the cannula or until the cannula is withdrawn from over the tool.


As described herein, upon creation of the cavity, the method can further include the insertion of a filler material or other substance into the cavity. The filler material can be delivered through the tool or through a separate cannula or catheter.


This disclosure also includes variations of devices for creating a cavity within bone or hard tissue. Such variations include devices for treating a vertebral body or other such structure. In one variation a device includes a handle having an actuating portion; a shaft comprising a first sleeve located concentrically within a second sleeve and a third sleeve located concentrically about the second sleeve, the shaft having a distal portion comprising a working end capable of moving between a linear configuration and an articulated configuration where the second articulated configuration is limited to a single plane, and where each sleeve comprises a series of slots or notches to limit deflection of the working end to the articulated configuration, where the respective series of slots or notches are radially offset in each sleeve; and a sharp tip located at a distal tip of the working end, the sharp tip adapted to penetrate vertebral bone within the vertebral body.


In one variation, the devices described herein can include a configuration where the first sleeve is affixed to the second sleeve at the working end such that proximal movement of the first sleeve causes the working end to assume the articulated configuration. The sleeves can be affixed at any portion along their length via a mechanical fixation means (e.g., a pin or other fixation means), an adhesive, or one or more weld points. In some variations, fixation of the sleeves occurs at the working end so that movement of the inner or first sleeve causes the working end to assume the curved configuration. In some cases, the third sleeve can be affixed outside of the working end so long as when the first and second sleeves articulate, the third sleeve still articulates.


Devices described herein can optionally include a force-limiting assembly coupled between the actuating portion and the first sleeve such that upon reaching a threshold force, the actuating portion disengages the first sleeve. In one variation, the force-limiting mechanism is adapted to limit force applied to bone when moving the working end from the first configuration toward the second configuration.


In additional variations, devices for creating cavities in bone or hard tissue can include one or more spring elements that extending through the first sleeve, where the spring element is affixed to the shaft (within or about either the first, second, or third sleeve). Such spring elements cause the working end to assume a linear configuration in a relaxed state.


In additional variations, a device can include an outer or third sleeve where the slots or notches (that allow deflection) are located on an exterior surface of the third sleeve. The exterior surface is typically the surface that faces outward from a direction of the curved configuration. This configuration allows for an interior surface (the surface located on the interior of the curved portion) to be smooth. As a result, if the device is withdrawn through tissue or a cannula or other introducer, the smooth surface on the interior of the curve minimizes the chance that the device becomes caught on the opening of the cannula or any other structure.


Variations of the device can include one or more lumens that extend through the shaft and working end. These lumens can exit at a distal tip of the device or through a side opening in a wall of the device. The lumen can include a surface comprising a lubricious polymeric material. For example, the material can comprise any bio-compatible material having low frictional properties (e.g., TEFLON®, a polytetrafluroethylene (PTFE), FEP (Fluorinated ethylenepropylene), polyethylene, polyamide, ECTFE (Ethylenechlorotrifluoro-ethylene), ETFE, PVDF, polyvinyl chloride and silicone).


As described herein, the devices can include any number of configurations to prevent rotation between adjacent sleeves but allow axial movement between the sleeves. For example, the sleeves can be mechanically coupled via a pin/slot or key/keyway configuration. In an additional variation, the sleeves can be non-circular to prevent rotation.


In an additional variation, the disclosure includes various kits comprising the device described herein as well as a filler material (e.g., a bone cement or other bone filler material).


Variations of the access device and procedures described above include combinations of features of the various embodiments or combination of the embodiments themselves wherever possible.


The methods, devices and systems described herein can be combined with the following commonly assigned patent applications and provisional applications, the entirety of each of which is incorporated by reference herein: Application No. 61/194,766, filed Sep. 30, 2008; Application No. 61/104,380, filed Oct. 10, 2008; Application No. 61/322,281, filed Apr. 8, 2010; application Ser. No. 12/571,174 filed Sep. 30, 2009; PCT Application number PCT/US2009/059113 filed Sep. 30, 2009; application Ser. No. 12/578,455 filed Oct. 13, 2009.





BRIEF DESCRIPTION OF DRAWINGS


FIG. 1 is a plan view of an osteotome of the invention.



FIG. 2 is a side view of the osteotome of FIG. 1.



FIG. 3 is a cross sectional view of the osteotome of FIG. 1.



FIG. 4 is an enlarged sectional view of the handle of the osteotome of FIG. 1.



FIG. 5 is an enlarged sectional view of the working end of the osteotome of FIG. 1.



FIG. 6A is a sectional view of the working end of FIG. 5 in a linear configuration.



FIG. 6B is a sectional view of the working end of FIG. 5 in a curved configuration.



FIGS. 7A-7C are schematic sectional views of a method of use of the osteotome of FIG. 1.



FIG. 8 is another embodiment of an osteotome working end.



FIG. 9 is another embodiment of an osteotome working end.



FIG. 10 is another variation of an osteotome with an outer sleeve.



FIG. 11 is a cut-away view of the working end of the osteotome of FIG. 10.



FIG. 12A is sectional view of another embodiment of working end, taken along line 12A-12A of FIG. 11.



FIGS. 12B and 12C illustrate additional variations of preventing rotation between adjacent sleeves.



FIG. 13 is sectional view of another working end embodiment similar to that of FIG. 11.



FIG. 14 is a cut-away perspective view of the working end of FIG. 13.



FIG. 15 illustrates a variation of an osteotome as described herein having electrodes on a tip of the device and another electrode on the shaft.



FIG. 16 illustrates an osteotome device as shown in FIG. 15 after being advanced into the body and where current passes between electrodes.



FIG. 17 illustrates a variation of a device as described herein further including a connector for providing energy at the working end of the device.



FIGS. 18A and 18B illustrate a device having a sharp tip as disclosed herein where the sharp tip is advanceable from the distal end of the shaft.



FIG. 19 shows a cross sectional view of the device illustrated in FIG. 18B and also illustrates temperature sensing elements located on device.



FIG. 20 shows a variation of a device where the inner sleeve is extended from the device and where current is applied between the extended portion of the inner sleeve and the shaft to treat tissue.



FIG. 21 illustrates a variation of a device as described herein further including an extendable helical electrode carried by the working end of the device.



FIGS. 22A and 22B illustrate the device of FIG. 21 with the helical electrode in a non-extended position and an extended position.



FIGS. 22C and 22D illustrate charts of variations of electrodes having ablated volumes given a particular duration of an ablation cycle.



FIG. 23 illustrates the working end of the device of FIG. 21 in a vertebral body with the helical electrode delivering Rf energy to tissue for ablation or other treatments.



FIG. 24 illustrates an alternative articulating ablation device with the working end including opposing polarity electrode surfaces on an outer radius of the articulated working end.



FIG. 25 depicts the articulated working end of FIG. 24 in a vertebral body delivering RF energy to tissue wherein an insulated surface directs energy away from the spinal canal.



FIG. 26 illustrates an alternative articulating device with the working end including a plurality of extendable electrodes extending from an outer radius of the articulated working end.



FIG. 27 depicts the articulated working end of FIG. 26 in a vertebral body applying RF energy to tissue wherein the plurality of extended electrodes directs energy away from the spinal canal.



FIG. 28 illustrates an alternative articulating ablation device with the working end including opposing polarity electrode surfaces and a source of an insulative flow media or gel coupleable to a lumen in the device.



FIG. 29 depicts the articulated working end of FIG. 28 in a vertebral body applying energy to tissue wherein an insulative gel directs the energy away from the spinal canal.





DETAILED DESCRIPTION

Referring to FIGS. 1-5, an apparatus or osteotome 100 is shown that is configured for accessing the interior of a vertebral body and for creating a pathway in vertebral cancellous bone to receive bone cement. In one embodiment, the apparatus is configured with an extension portion or member 105 for introducing through a pedicle and wherein a working end 110 of the extension member can be progressively actuated to curve a selected degree and/or rotated to create a curved pathway and cavity in the direction of the midline of the vertebral body. The apparatus can be withdrawn and bone fill material can be introduced through a bone cement injection cannula. Alternatively, the apparatus 100 itself can be used as a cement injector with the subsequent injection of cement through a lumen 112 of the apparatus.


In one embodiment, the apparatus 100 comprises a handle 115 that is coupled to a proximal end of the extension member 105. The extension member 105 comprises an assembly of first (outer) sleeve 120 and a second (inner) sleeve 122, with the first sleeve 120 having a proximal end 124 and distal end 126. The second sleeve 122 has a proximal end 134 and distal end 136. The extension member 105 is coupled to the handle 115, as will be described below, to allow a physician to drive the extension member 105 into bone while contemporaneously actuating the working end 110 into an actuated or curved configuration (see FIG. 6). The handle 115 can be fabricated of a polymer, metal or any other material suitable to withstand hammering or impact forces used to drive the assembly into bone (e.g., via use of a hammer or similar device on the handle 115). The inner and outer sleeves are fabricated of a suitable metal alloy, such as stainless steel or NiTi. The wall thicknesses of the inner and outer sleeves can range from about 0.005″ to 0.010″ with the outer diameter the outer sleeve ranging from about 2.5 mm to 5.0 mm.


Referring to FIGS. 1, 3 and 4, the handle 115 comprises both a first grip portion 140 and a second actuator portion indicated at 142. The grip portion 140 is coupled to the first sleeve 120 as will be described below. The actuator portion 142 is operatively coupled to the second sleeve 122 as will be described below. The actuator portion 142 is rotatable relative to the grip portion 140 and one or more plastic flex tabs 145 of the grip portion 140 are configured to engage notches 146 in the rotatable actuator portion 142 to provide tactile indication and temporary locking of the handle portions 140 and 142 in a certain degree of rotation. The flex tabs 145 thus engage and disengage with the notches 146 to permit ratcheting (rotation and locking) of the handle portions and the respective sleeve coupled thereto.


The notches or slots in any of the sleeves can comprise a uniform width along the length of the working end or can comprise a varying width. Alternatively, the width can be selected in certain areas to effectuate a particular curved profile. In other variation, the width can increase or decrease along the working end to create a curve having a varying radius. Clearly, it is understood that any number of variations are within the scope of this disclosure.



FIG. 4 is a sectional view of the handle showing a mechanism for actuating the second inner sleeve 122 relative to the first outer sleeve 120. The actuator portion 142 of the handle 115 is configured with a fast-lead helical groove indicated at 150 that cooperates with a protruding thread 149 of the grip portion 140 of the handle. Thus, it can be understood that rotation of the actuation portion 142 will move this portion to the position indicated at 150 (phantom view). In one embodiment, when the actuator portion 142 is rotated a selected amount from about 45° to 720°, or from about 90° to 360°, the inner sleeve 122 is lifted proximally relative to the grip portion 140 and outer sleeve 120 to actuate the working end 110. As can be seen in FIG. 4 the actuator portion 142 engages flange 152 that is welded to the proximal end 132 of inner sleeve 122. The flange 152 is lifted by means of a ball bearing assembly 154 disposed between the flange 152 and metal bearing surface 155 inserted into the grip portion 140 of the handle. Thus, the rotation of actuator 142 can lift the inner sleeve 122 without creating torque on the inner sleeve.


Now turning to FIGS. 5, 6A and 6B, it can be seen that the working end 110 of the extension member 105 is articulated by cooperating slotted portions of the distal portions of outer sleeve 120 and inner sleeve 122 that are both thus capable of bending in a substantially tight radius. The outer sleeve 120 has a plurality of slots or notches 162 therein that can be any slots that are perpendicular or angled relative to the axis of the sleeve. The inner sleeve 122 has a plurality of slots or notches indicated at 164 that can be on an opposite side of the assembly relative to the slots 162 in the outer sleeve 120. The outer and inner sleeves are welded together at the distal region indicated at weld 160. It thus can be understood that when inner sleeve 122 is translated in the proximal direction, the outer sleeve will be flexed as depicted in FIG. 6B. It can be understood that by rotating the actuator handle portion 142 a selected amount, the working end can be articulated to a selected degree.



FIGS. 4, 5, 6A and 6B further illustrate another element of the apparatus that comprises a flexible flat wire member 170 with a proximal end 171 and flange 172 that is engages the proximal side of flange 152 of the inner sleeve 122. At least the distal portion 174 of the flat wire member 170 is welded to the inner sleeve at weld 175. This flat wire member thus provides a safety feature to retain the working end in the event that the inner sleeve fails at one of the slots 164.


Another safety feature of the apparatus comprises a torque limiter and release system that allows the entire handle assembly 115 to freely rotate—for example if the working end 110 is articulated, as in FIG. 6B, when the physician rotates the handle and when the working end is engaged in strong cancellous bone. Referring to FIG. 4, the grip portion 142 of the handle 115 engages a collar 180 that is fixed to a proximal end 124 of the outer sleeve 120. The collar 180 further comprises notches 185 that are radially spaced about the collar and are engaged by a ball member 186 that is pushed by a spring 188 into notches 185. At a selected force, for example a torque ranging from greater than about 0.5 inch*lbs but less that about 7.5 inch*lbs, 5.0 inch*lbs or 2.5 inch*lbs, the rotation of the handle 115 overcomes the predetermined limit. When the torque limiter assembly is in its locked position, the ball bearing 186 is forced into one of the notches 185 in the collar 180. When too much torque is provided to the handle and outer sleeve, the ball bearing 186 disengages the notch 185 allowing the collar 180 to turn, and then reengages at the next notch, releasing anywhere from 0.5 inch*lbs to 7.5 inch*lbs of torque.


Referring to FIGS. 6A and 6B, it can be understood that the inner sleeve 122 is weakened on one side at its distal portion so as to permit the inner sleeve 122 to bend in either direction but is limited by the location of the notches in the outer sleeve 120. The curvature of any articulated configuration is controlled by the spacing of the notches as well as the distance between each notch peak. The inner sleeve 122 also has a beveled tip for entry through the cortical bone of a vertebral body. Either the inner sleeve or outer sleeve can form the distal tip.


Referring to FIGS. 7A-7C, in one variation of use of the device, a physician taps or otherwise drives a stylet 200 and introducer sleeve 205 into a vertebral body 206 typically until the stylet tip 208 is within the anterior ⅓ of the vertebral body toward cortical bone 210 (FIG. 7A). Thereafter, the stylet 200 is removed and the sleeve 205 is moved proximally (FIG. 7B). As can be seen in FIG. 7B, the tool or osteotome 100 is inserted through the introducer sleeve 205 and articulated in a series of steps as described above. The working end 110 can be articulated intermittently while applying driving forces and optionally rotational forces to the handle 115 to advance the working end through the cancellous bone 212 to create path or cavity 215. The tool is then tapped to further drive the working end 110 to, toward or past the midline of the vertebra. The physician can alternatively articulate the working end 110, and drive and rotate the working end further until imaging shows that the working end 100 has created a cavity 215 of an optimal configuration. Thereafter, as depicted in FIG. 7C, the physician reverses the sequence and progressively straightens the working end 110 as the extension member is withdrawn from the vertebral body 206. Thereafter, the physician can insert a bone cement injector 220 into the path or cavity 215 created by osteotome 100. FIG. 7C illustrates a bone cement 222, for example a PMMA cement, being injected from a bone cement source 225.


In another embodiment (not shown), the apparatus 100 can have a handle 115 with a Luer fitting for coupling a bone cement syringe and the bone cement can be injected through the lumen 112 of the apparatus. In such an embodiment FIG. 9, the lumen can have a lubricious surface layer or polymeric lining 250 to insure least resistance to bone cement as it flows through the lumen. In one embodiment, the surface or lining 250 can be a fluorinated polymer such as TEFLON® or polytetrafluroethylene (PTFE). Other suitable fluoropolymer resins can be used such as FEP and PFA. Other materials also can be used such as FEP (Fluorinated ethylenepropylene), ECTFE (Ethylenechlorotrifluoro-ethylene), ETFE, Polyethylene, Polyamide, PVDF, Polyvinyl chloride and silicone. The scope of the invention can include providing a polymeric material having a static coefficient of friction of less than 0.5, less than 0.2 or less than 0.1.



FIG. 9 also shows the extension member or shaft 105 can be configured with an exterior flexible sleeve indicated at 255. The flexible sleeve can be any commonly known biocompatible material, for example, the sleeve can comprise any of the materials described in the preceding paragraph.


As also can be seen in FIG. 9, in one variation of the device 100, the working end 110 can be configured to deflect over a length indicated at 260 in a substantially smooth curve. The degree of articulation of the working end 100 can be at least 45°, 90°, 135° or at least 180° as indicated at 265 (FIG. 9). In additional variations, the slots of the outer 120 and inner sleeves 120 can be varied to produce a device having a radius of curvature that varies among the length 260 of the device 100.


In another embodiment of the invention, the inner sleeve can be spring loaded relative the outer sleeve, in such a way as to allow the working end to straighten under a selected level of force when pulled in a linear direction. This feature allows the physician to withdraw the assembly from the vertebral body partly or completely without further rotation the actuating portion 142 of handle 115. In some variations, the force-limiter can be provided to allow less than about 10 inch*lbs of force to be applied to bone.


In another embodiment shown in FIG. 8, the working end 110 is configured with a tip 240 that deflects to the position indicated at 240′ when driven into bone. The tip 240 is coupled to the sleeve assembly by resilient member 242, for example a flexible metal such as stainless steel or NiTi. It has been found that the flexing of the tip 240 causes its distal surface area to engage cancellous bone which can assist in deflecting the working end 110 as it is hammered into bone.


In another embodiment of the invention (not shown), the actuator handle can include a secondary (or optional) mechanism for actuating the working end. The mechanism would include a hammer-able member with a ratchet such that each tap of the hammer would advance assembly and progressively actuate the working end into a curved configuration. A ratchet mechanism as known in the art would maintain the assembly in each of a plurality of articulated configurations. A release would be provided to allow for release of the ratchet to provide for straightening the extension member 105 for withdrawal from the vertebral body.



FIGS. 10 and 11 illustrate another variation of a bone treatment device 400 with a handle 402 and extension member 405 extending to working end 410 having a similar construction to that FIGS. 1 to 6B. The device 400 operates as described previously with notched first (outer) sleeve 120 and cooperating notched second (inner) sleeve 122. However, the variation shown in FIGS. 10 and 11 also includes a third concentric notched sleeve 420, exterior to the first 120 and second 122 sleeves. The notches or slots in sleeve 420 at the working end 410 permit deflection of the sleeve as indicated at 265 in FIG. 11.



FIG. 10 also illustrates the treatment device 400 as including a luer fitting 412 that allows the device 400 to be coupled to a source 414 of a filler material (e.g., a bone filler or bone cement material). The luer can be removable from the handle 402 to allow application of an impact force on the handle as described above. Moreover, the luer fitting 412 can be located on the actuating portion of the handle, the stationary part of the handle or even along the sleeve. In any case, variations of the device 400 permit coupling the filler material with a lumen extending through the sleeves (or between adjacent sleeves) to deposit filler material at the working end 410. As shown by arrows 416, filler material can be deposited through a distal end of the sleeves (where the sharp tip is solid) or can be deposited through openings in a side-wall of the sleeves. Clearly, variations of this configuration are within the scope of those familiar in the field.


In some variations, the third notched sleeve 420 is configured with its smooth (non-notched) surface 424 disposed to face inwardly on the articulated working end (FIG. 11) such that a solid surface forms the interior of the curved portion of the working end 410. The smooth surface 424 allows withdrawal of the device 110 into a cannula or introducer 205 without creating a risk that the slots or notches become caught on a cannula 205 (see e.g., FIG. 7B).


As shown in FIGS. 10-11, the third (outermost) sleeve 420 can extend from an intermediate location on the extension member 405 to a distal end of the working end 410. However, variations of the device include the third sleeve 420 extending to the handle 402. However, the third sleeve 420 is typically not coupled to the handle 402 so that any rotational force or torque generated by the handle 402 is not directly transmitted to the third sleeve 420.


In one variation, the third sleeve 420 is coupled to the second sleeve 120 at only one axial location. In the illustrated example shown in FIG. 11, the third sleeve 420 is affixed to second sleeve 420 by welds 428 at the distal end of the working end 410. However, the welds or other attachment means (e.g., a pin, key/keyway, protrusion, etc.) can be located on a medial part of the sleeve 420. The sleeve 420 can be fabricated of any bio-compatible material. For example, in one variation, the third sleeve is fabricated form a 3.00 mm diameter stainless steel material with a wall thickness of 0.007″. The first, second and third sleeves are sized to have dimensions to allow a sliding fit between the sleeves.



FIG. 12A is a sectional view of extension member 405 of another variation, similar to that shown in FIGS. 10-11. However, the variation depicted by FIG. 12A comprises non-round configurations of concentric slidable sleeves (double or triple sleeve devices). This configuration limits or prevents rotation between the sleeves and allows the physician to apply greater forces to the bone to create a cavity. While FIG. 12A illustrates an oval configuration, any non-round shape is within the scope of this disclosure. For example, the cross-sectional shape can comprise a square, polygonal, or other radially keyed configuration as shown in FIGS. 12B and 12C. As shown in FIG. 12C the sleeves can include a key 407 and a receiving keyway 409 to prevent rotation but allow relative or axial sliding of the sleeves. The key can comprise any protrusion or member that slides within a receiving keyway. Furthermore, the key can comprise a pin or any raised protrusion on an exterior or interior of a respective sleeve. In this illustration, only the first 122 and second 120 sleeves are illustrated. However, any of the sleeves can be configured with the key/keyway. Preventing rotation between sleeves improves the ability to apply force to bone at the articulated working end.



FIGS. 13-14 illustrate another variation of a working end 410 of an osteotome device. In this variation, the working end 410 includes one or more flat spring elements 450, 460a, 460b, 460c, 460d, that prevent relative rotation of the sleeves of the assembly thus allowing greater rotational forces to be applied to cancellous bone from an articulated working end. The spring elements further urge the working end assembly into a linear configuration. To articulate the sleeves, a rotational force is applied to the handle as described above, once this rotational force is removed, the spring elements urge the working end into a linear configuration. As shown in FIG. 13, one or more of the spring elements can extend through the sleeves for affixing to a handle to prevent rotation. Furthermore, the distal end 454 of flat spring element 450 is fixed to sleeve assembly by weld 455. Thus, the spring element is fixed at each end to prevent its rotation. Alternate variations include one or more spring elements being affixed to the inner sleeve assembly at a medial section of the sleeve.


As shown in FIGS. 13-14, variations of the osteotome can include any number of spring elements 460a-460d. These additional spring elements 460a-460d can be welded at either a proximal or distal end thereof to an adjacent element or a sleeve to allow the element to function as a leaf spring.


In an additional variation, the osteotome device can include one or more electrodes 310, 312 as shown in FIG. 15. In this particular example, the device 300 includes spaced apart electrodes having opposite polarity to function in a bi-polar manner. However, the device can include a monopolar configuration. Furthermore, one or more electrodes can be coupled to individual channels of a power supply so that the electrodes can be energized as needed. Any variation of the device described above can be configured with one or more electrodes as described herein.



FIG. 16 illustrates an osteotome device 300 after being advanced into the body as discussed above. As shown by lines 315 representing current flow between electrodes, when required, the physician can conduct RF current between electrodes 310 and 312 to apply coagulative or ablative energy within the bone structure of the vertebral body (or other hard tissue). While FIG. 16 illustrates RF current 315 flow between electrodes 310 and 312, variations of the device can include a number of electrodes along the device to apply the proper therapeutic energy. Furthermore, an electrode can be spaced from the end of the osteotome rather than being placed on the sharp tip as shown by electrode 310. In some variations, the power supply is coupled to the inner sharp tip or other working end of the first sleeve. In those variations with only two sleeves, the second pole of the power supply is coupled with the second sleeve (that is the exterior of the device) to form a return electrode. However, in those variations having three sleeves, the power supply can alternatively be coupled with the third outer sleeve. In yet additional variations, the second and third sleeves can both function as return electrodes. However, in those devices that are monopolar, the return electrode will be placed outside of the body on a large area of skin.



FIGS. 17 to 20 illustrate another variation of an articulating probe or osteotome device 500. In this variation, the device 500 includes a working end 505 that carries one or more RF electrodes that can be used to conduct current therethrough. Accordingly, the device can be used to sense impedance of tissue, locate nerves, or simply apply electrosurgical energy to tissue to coagulate or ablate tissue. In one potential use, the device 500 can apply ablative energy to a tumor or other tissue within the vertebra as well as create a cavity.



FIGS. 17, 18A, 18B and 19, illustrate a variation of the device 500 as having a handle portion 506 coupled to a shaft assembly 510 that extends along axis 512 to the articulating working end 505. The articulating working end 505 can be actuatable as described above. In addition, FIG. 17 shows that handle component 514a can be rotated relative to handle component 514b to cause relative axial movement between a first outer sleeve 520 and second inner sleeve 522 (FIG. 19) to cause the slotted working ends of the sleeve assembly to articulate as described above. The working end 505 of FIG. 19 shows two sleeves 520 and 522 that are actuatable to articulate the working end, but it should be appreciated that a third outer articulating sleeve can be added as depicted above. In one variation, the articulating working end can articulate 90° by rotating handle component 514a between ¼ turn and ¾ turn. The rotating handle component 514a can include detents at various rotational positions to allow for controlled hammering of the working end into bone. For example, the detents can be located at every 45° rotation or can be located at any other rotational increment.



FIG. 17 depict an RF generator 530A and RF controller 530B connectable to an electrical connector 532 in the handle component 514a with a plug connector indicated at 536. The RF generator is of the type known in the art for electrosurgical ablation. The outer sleeve 520 comprises a first polarity electrode indicated at 540A (+). However, any energy modality can be employed with the device.



FIGS. 18A and 18B illustrate yet another variation of a working end of a device for creating cavities in hard tissue. As shown, the device 500 can include a central extendable sleeve 550 with a sharp tip 552 that is axially extendable from passageway 554 of the assembly of first and second sleeves 520 and 522 (FIG. 19). The sleeve 550 can also include a second polarity electrode indicated at 540B (−). Clearly, the first and second electrodes will be electrically insulated from one another. In one variation, and as shown in FIG. 19, the sleeve assembly can carry a thin sleeve 555 or coating of an insulative polymer such as PEEK to electrically isolate the first polarity electrode 540A (+) from the second polarity electrode 540B (−). The electrode can be deployed by rotating knob 558 on the striking surface of handle component 514a (FIG. 17). The degree of extension of central sleeve 550 can optionally be indicated by a slider tab 557 on the handle. In the illustrated variation, the slider tab is located on either side of handle component 514a (FIG. 17). Sleeve 550 can be configured to extend distally beyond the assembly of sleeves 520 and 522 a distance of about 5 to 15 mm.


Referring to FIG. 19, the central extendable sleeve 550 can have a series of slots in at least a distal portion thereof to allow it to bend in cooperation with the assembly of first and second sleeves 520 and 522. In the embodiment shown in FIG. 18B, the central sleeve 550 can optionally include a distal portion that does not contain any slots. However, additional variations include slots on the distal portion of the sleeve.



FIG. 19 further depicts an electrically insulative collar 560 that extends length A to axially space apart the first polarity electrode 540A (+) from the second polarity electrode 540B (−). The axial length A can be from about 0.5 to 10 mm, and usually is from 1 to 5 mm. The collar can be a ceramic or temperature resistant polymer.



FIG. 19 also depicts a polymer sleeve 565 that extends through the lumen in the center of electrode sleeve 550. The polymer sleeve 565 can provide saline infusion or other fluids to the working end and/or be used to aspirate from the working end when in use. The distal portion of sleeve 550 can include one or more ports 566 therein for delivering fluid or aspirating from the site.


In all other respects, the osteotome system 500 can be driven into bone and articulated as described above. The electrodes 540A and 540B are operatively coupled to a radiofrequency generator as is known in the art for applying coagulative or ablative electrosurgical energy to tissue. In FIG. 20, it can be seen that RF current 575 is indicated in paths between electrodes 540A and 540B as shown by lines 575. RF generator 530A and controller 530B for use with the devices described herein can include any number of power settings to control the size of targeted coagulation or ablation area. For example, the RF generator and controller can have Low (5 watts), medium (15 Watts) and High (25 watts) power settings. The controller 530B can have a control algorithm that monitors the temperature of the electrodes and changes the power input in order to maintain a constant temperature. At least one temperature sensing element (e.g., a thermocouple) can be provided on various portions of the device. For example, and as shown in FIG. 19, a temperature sensing element 577 can be provided at the distal tip of sleeve 550 tip while a second temperature sensing element 578 can be provided proximal from the distal tip to provide temperature feedback to the operator to indicate the region of ablated tissue during the application of RF energy. In one example, the second temperature sensing element was located approximately 15 to 20 mm from the distal tip.



FIG. 21 illustrates another variation of articulating osteotome 600 with RF ablation features. Variations of the illustrated osteotome 600 can be similar to the osteotome of FIGS. 17-18B. In this variation, the osteotome 600 has a handle 602 coupled to shaft assembly 610 as described above. The working end 610 again has an extendable assembly indicated at 615 in FIG. 21 that can be extended by rotation of handle portion 622 relative to handle 602. The osteotome can be articulated as described previously by rotating handle portion 620 relative to handle 602.



FIGS. 22A-22B are views of the working end 610 of FIG. 21 in a first non-extended configuration (FIG. 22A) and a second extended configuration (FIG. 22B). As can be seen in FIGS. 22A-22B, the extension portion 615 comprises an axial shaft 624 together with a helical spring element 625 that is axially collapsible and extendible. In one embodiment, the shaft can be a tube member with ports 626 fluidly coupled to a lumen 628 therein. In some variations, the ports can carry a fluid to the working end or can aspirate fluid from the working end.


In FIGS. 22A-22B, it can be seen that axial shaft 624, helical spring element 625 together with sharp tip 630 comprise a first polarity electrode (+) coupled to electrical source 530A and controller 530B as described previously. An insulator 632 separates the helical spring 625 electrode from the more proximal portion of the sleeve which comprises opposing polarity electrode 640 (−). The RF electrodes can function as described above (see FIG. 20) to ablate tissue or otherwise deliver energy to tissue.


In one variation, the extension portion 615 can extend from a collapsed spring length of 2 mm, 3 mm, 4 mm or 5 mm to an extended spring length of 6 mm, 7 mm, 8 mm, 9 mm 10 mm or more. In the working end embodiment 615 in FIG. 22B, the spring can comprise a flat rectangular wire that assists in centering the spring 625 about shaft 624 but still can collapse to short overall length, with the flat surfaces of rectangular wire oriented for stacking. However, other variations are within the scope of the variations described herein.


The use of the spring 625 as an electrode provides significant improvements in delivering energy. This spring provides (i) greatly increased electrode surface area and (ii) a very greatly increased length of relatively sharp edges provided by the rectangular wire—which provides for edges. Because the edges provide low surface area the concentration or density of RF current is greater at the edges and allows for the RF current to jump or arc. Both these aspects of the invention—increased electrode surface area and increased electrode edge length—allow for much more rapid tissue ablation.


In one aspect of the invention, the surface area of the spring electrode 625 can be at least 40 mm2, at least 50 mm2, or at least 60 mm2 over the spring electrode lengths described above.


In another aspect of the invention, the total length of the 4 edges of rectangular wire spring can be greater than 50 mm, greater than 100 mm or greater than 150 mm over the spring electrode lengths described above.


In one example used in testing, an osteotome 600 (as in FIG. 21-22B) was configured with a helical spring that had a collapsed length of 1.8 mm and an extended length of 7.5 mm. In this embodiment, the surface area of the spring electrode 625 when extended was 64.24 mm2 and the total length of the electrodes edges was 171.52 mm (four edges at 42.88 mm per edge).


In a comparison test, a first osteotome without a helical electrode was compared against a second osteotome 600 with a helical electrode as in FIG. 22B. These devices were evaluated at different power levels and different energy delivery intervals to determine volume of ablation. The working ends of the devices had similar dimensions excepting for the helical spring electrode. Referring to FIG. 22C, RF energy was delivered at a low power setting of 5 Watts. It can be seen in FIG. 22C that at a treatment interval of 120 seconds and 5 W, the volume of ablation was about 3 times faster with the helical electrode compared to the working end without the helical electrode (1.29 cc vs. 0.44 cc).


Another comparison test of the same first osteotome 500 (FIG. 18B) and second osteotome 600 with a helical electrode (FIG. 22B) were evaluated at higher 15 Watt power level. As can be seen in FIG. 22D, RF energy at a treatment interval of 25 seconds and 15 W, the volume of ablation was again was about 3 times faster with the helical electrode compared to the working end without the helical electrode (1.00 cc vs. 0.37 cc). Referring to FIG. 22D, the device without the helical electrode impeded out before 60 seconds passed, so that data was not provided. The testing shows that the helical electrode is well suited for any type of tissue or tumor ablation, with a 60 second ablation resulting in 1.63 cc of ablated tissue.



FIG. 23 schematically illustrates the osteotome 600 in use in a vertebral body, wherein the RF current between the electrodes 625 and 640 ablate a tissue volume indicated at 650.



FIG. 24 illustrates another variation of an articulating osteotome 700 with the ability to supply RF energy. Some variations of the device can be fabricated to be similar to the osteotome of FIGS. 17-18B. In one variation, the shaft assembly 705 is similar to previous examples where the working end 710 carries an extendable element 725 that carries an electrode surface indicated at 727 in FIG. 24. The extendable element 725 can be actuated by extension of flexible sleeve 722 disposed in a lumen in a shaft assembly 705. For example, the flexible sleeve 722 and extendable element 725 can be extended by rotation of a handle mechanism as describe above. The osteotome is articulated as described previously by rotation of a first handle portion relative to a second handle portion.


Still referring to FIG. 24, the extendable electrode 727 can be coupled to a first pole of an electrical source 530A, and the shaft 705 can comprises the opposing polarity electrode surface 740 coupled to a second pole of electrical source 530A. An insulator collar 732 separates the first and second polarity electrode surfaces 727 and 740. In some variations, the collar 732 carries an insulative coating or is fabricated from an insulative material. As can be seen in FIG. 24, the posterior facing surface of extendable element 725 carries an electrical insulator 744 including, but not limited to a paint, coating, tape, polymer, ceramic or the like. Further, the inner radius of the articulated shaft 705 carries an electrical insulator 745 which again can be a paint, coating, tape, polymer body portion, ceramic or the like.



FIG. 25 depicts the articulated working end of FIG. 24 in a vertebral body delivering RF energy to tissue wherein the insulated surfaces 744 and 745 directs heating of tissue on the opposite side of the device so that the energy delivery occurs away from the spinal canal 748. In some variations, the energy produces an ablated region indicated at 750. However, the devices described herein can include any variety of energy delivery whether ablative or non-ablative.



FIG. 26 depicts another embodiment of articulating osteotome 800 with RF ablation functionality. In one embodiment, the shaft assembly 805 is similar to previous embodiments with the working end 810 carrying a plurality of extendable electrodes 825 that can be extended by an actuator mechanism in the handle. The osteotome can articulate as described previously by rotation of a first handle portion relative to a second handle portion. The extendable electrodes 825 cooperate with shaft electrode 840 as described previously, and are separated from the shaft electrode 840 by insulative sleeves 832. The embodiment of FIG. 26 further carries an axially-extending insulator 845 on the inner radius of the shaft.


In general, the osteotome 800 of FIG. 26 comprises a handle having a connector for electrically coupling the device to a power supply, a shaft 805 having an axis extending from the handle to a working end 810, where a first conductive portion of the shaft is electrically coupleable to a first pole of a RF power supply, a plurality of extendable electrode elements 825 extendible from the shaft, where the extendable elements 825 are coupleable to a second pole of the power supply, such that when activated, current flows between the extendable elements and the shaft, and wherein the extendible elements are radially asymmetric relative to the axis of the shaft 805.



FIG. 27 depicts the articulated working end of FIG. 26 in a vertebral body applying energy to tissue wherein the plurality of extended electrodes 825 deliver energy in a region 850 that is spaced away from spinal canal 748.



FIG. 28 illustrates an alternative articulating ablation device 900 with RF ablation functionality. In one embodiment, the shaft or extension portion 905 comprises two components. One component 910 can be an articulating assembly as in previous embodiments or can be a NiTi sleeve that extends to the working end 910 and carries an extendable electrode 925 that can be extended by an actuator mechanism in the handle. The second component 930 of the extension portion comprises a flexible polymer sleeve or a NiTi sleeve that had a lumen therein for carrying a flow media to outlets 932 in the working end 910. Electrodes 925 and 940 function as previously described.


The embodiment of FIG. 28 includes a source 960 of an electrically and/or thermally insulative fluid or gel 965 that can be injected in the tissue site to protect selected tissue from ablation. In general, an osteotome of the invention comprises a handle having a connector for electrically coupling the osteotome device to a power supply, a shaft extending from the handle to a working end, where a first and second conductive portions of the shaft are coupleable to a first and second poles of a power supply, and a lumen in the shaft coupleable to a source of insulative flowable media.



FIG. 29 depicts the articulated working end of FIG. 28 in a vertebral body applying RF energy to ablate tissue wherein an insulative gel 965 is injected to protect the spinal canal 748 to thereby create an ablate region 950 away from the spinal canal.


Although particular embodiments of the present invention have been described above in detail, it will be understood that this description is merely for purposes of illustration and the above description of the invention is not exhaustive. Specific features of the invention are shown in some drawings and not in others, and this is for convenience only and any feature may be combined with another in accordance with the invention. A number of variations and alternatives will be apparent to one having ordinary skills in the art. Such alternatives and variations are intended to be included within the scope of the claims. Particular features that are presented in dependent claims can be combined and fall within the scope of the invention. The invention also encompasses embodiments as if dependent claims were alternatively written in a multiple dependent claim format with reference to other independent claims.

Claims
  • 1. A method of applying targeted energy within a vertebral bone tissue, the method comprising: inserting an osteotome into the bone tissue, the osteotome comprising a first electrode along an anterior surface and an insulator along a posterior surface;articulating a distal portion of the osteotome in a posterior direction;extending an extendable member comprising a second electrode along an anterior surface and an insulator along a posterior surface;applying energy to the second electrode;dispersing the energy into the bone tissue; anddirecting the energy anteriorly from the second electrode to the vertebral bone tissue.
  • 2. The method of applying targeted energy within a vertebral bone tissue of claim 1, further comprising directing the energy away from the spinal canal.
  • 3. The method of applying targeted energy within a vertebral bone tissue of claim 1, wherein the energy applied to the second electrode is a radio frequency energy.
  • 4. The method of applying targeted energy within a vertebral bone tissue of claim 1, further comprising monitoring a temperature of the bone tissue.
  • 5. The method of applying targeted energy within a vertebral bone tissue of claim 1, further comprising forming a cavity in the bone tissue.
  • 6. The method of applying targeted energy within a vertebral bone tissue of claim 1, further comprising inserting an introducer into the vertebral bone tissue.
  • 7. The method of applying targeted energy within a vertebral bone tissue of claim 6, further comprising: removing the osteotome from the bone tissue through the introducer; andinjecting a filler material into the cavity.
  • 8. The method of applying targeted energy within a vertebral bone tissue of claim 7, wherein the filler material is bone cement and/or bone filler.
  • 9. The method of applying targeted energy within a vertebral bone tissue of claim 1, wherein articulating the osteotome comprises applying impact forces on a portion of the osteotome.
  • 10. The method of applying targeted energy within a vertebral bone tissue of claim 1, wherein articulating the osteotome comprises applying a rotational force to a portion of osteotome to shorten a side of the osteotome.
  • 11. The method of applying targeted energy within a vertebral bone tissue of claim 1, wherein the energy causes coagulative necrosis of the bone tissue.
  • 12. A method of applying targeted energy within a hard tissue, the method comprising: inserting an apparatus through an introducer into the hard tissue, the apparatus comprising an electrode disposed along one side and an insulator along an opposite side;causing a distal portion of the apparatus to move from a linear configuration to a curved configuration;extending an apparatus extension from the apparatus into the hard tissue, wherein the apparatus extension comprises an electrode strip disposed along one side and an insulator disposed along an opposite side;applying energy to the apparatus;dispersing the energy from the apparatus into the hard tissue; anddirecting the energy toward the hard tissue on one side of the distal portion.
  • 13. The method of applying targeted energy within the hard tissue of claim 12, wherein the energy applied to the apparatus is a radio frequency energy.
  • 14. The method of applying targeted energy within the hard tissue of claim 12, further comprising monitoring a temperature of the hard tissue.
  • 15. The method of applying targeted energy within the hard tissue of claim 12, further comprising forming a cavity in the hard tissue.
  • 16. The method of applying targeted energy within the hard tissue of claim 12, further comprising inserting an introducer into the hard tissue.
  • 17. The method of applying targeted energy within the hard tissue of claim 16, further comprising: removing the apparatus from the hard tissue through the introducer; andinjecting filler material into the cavity.
  • 18. The method of applying targeted energy within the hard tissue of claim 17, wherein the filler material is tissue cement and/or tissue filler.
  • 19. The method of applying targeted energy within the hard tissue of claim 12, wherein the distal portion of the apparatus is advanced into the hard tissue from impact forces on a proximal portion of the apparatus.
  • 20. The method of applying targeted energy within the hard tissue of claim 12, wherein the distal portion of the apparatus is articulated by rotation of a portion of the apparatus to shorten a side of the distal portion.
  • 21. The method of applying targeted energy within the hard tissue of claim 12, wherein the energy causes coagulative necrosis of the hard tissue.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 14/815,620 filed Jul. 31, 2015, which is a continuation of U.S. patent application Ser. No. 13/098,116 filed Apr. 29, 2011, now issued as U.S. Pat. No. 9,125,671, which claims the benefit of priority to U.S. Provisional Patent Application No. 61/329,394, filed on Apr. 29, 2010, the contents of each of which are incorporated herein by reference in its entirety.

US Referenced Citations (623)
Number Name Date Kind
2688329 Wallace Sep 1954 A
3140623 Hoose Jul 1964 A
3228400 Armao Jan 1966 A
3503385 Stevens Mar 1970 A
3625200 Muller Dec 1971 A
3664344 Bryne May 1972 A
3794039 Kollner et al. Feb 1974 A
3908637 Doroshow Sep 1975 A
4033331 Guss et al. Jul 1977 A
4131597 Bluethgen et al. Dec 1978 A
4236520 Anderson Dec 1980 A
4276880 Malmin Jul 1981 A
4294251 Grennwald et al. Oct 1981 A
4337773 Raftopoulos et al. Jul 1982 A
4386717 Koob Jun 1983 A
4399814 Pratt, Jr. et al. Aug 1983 A
4411266 Cosman Oct 1983 A
4456017 Miles Jun 1984 A
4473077 Noiles Sep 1984 A
4476861 Dimakos et al. Oct 1984 A
4578061 Lemelson Mar 1986 A
4586923 Gould et al. May 1986 A
4595006 Burke et al. Jun 1986 A
4619263 Frisbie et al. Oct 1986 A
4627434 Murray Dec 1986 A
4641654 Samson et al. Feb 1987 A
4653489 Tronzo Mar 1987 A
4668295 Bajpai May 1987 A
4719968 Speros Jan 1988 A
4722948 Sanderson Feb 1988 A
4731054 Billeter et al. Mar 1988 A
4742817 Kawashima et al. May 1988 A
4747840 Ladika et al. May 1988 A
4748969 Wardle Jun 1988 A
4784638 Ghajar et al. Nov 1988 A
4795602 Pretchel et al. Jan 1989 A
4842603 Draenert Jun 1989 A
4843112 Gerhart et al. Jun 1989 A
4846814 Ruiz Jul 1989 A
4865586 Hedberg Sep 1989 A
4869906 Dingeldein et al. Sep 1989 A
4888366 Chu et al. Dec 1989 A
4900303 Lemelson Feb 1990 A
4961730 Bodicky et al. Oct 1990 A
4961731 Bodicky Oct 1990 A
4963151 Ducheyene et al. Oct 1990 A
4969870 Kramer et al. Nov 1990 A
4969888 Scholten et al. Nov 1990 A
4982730 Royce Jan 1991 A
5059193 Kuslich Jan 1991 A
4998923 Samson et al. Mar 1991 A
5004501 Faccioli Apr 1991 A
5017627 Bonfield May 1991 A
5046513 O'Leary et al. Sep 1991 A
5049137 Thompson Sep 1991 A
5049157 Mittelmeier et al. Sep 1991 A
5085861 Gerhart et al. Feb 1992 A
5088991 Weldon Feb 1992 A
5116305 Milder et al. Feb 1992 A
5092891 Kummer et al. Mar 1992 A
5103804 Abele Apr 1992 A
5108404 Scholten et al. Apr 1992 A
5112303 Pudenz et al. May 1992 A
5114414 Buchbinder May 1992 A
5147334 Moss Sep 1992 A
5156606 Chin Oct 1992 A
5163431 Greip Nov 1992 A
5184757 Giannuzzi Feb 1993 A
5188619 Myers Feb 1993 A
5196201 Larsson et al. Mar 1993 A
5197971 Bonutti Mar 1993 A
5211631 Sheaff May 1993 A
5231989 Middleman et al. Aug 1993 A
5242082 Giannuzzi Sep 1993 A
5264214 Rhee et al. Nov 1993 A
5266248 Ohtsuka et al. Nov 1993 A
5269750 Grulke et al. Dec 1993 A
5282821 Donahue Feb 1994 A
5284128 Hart Feb 1994 A
5285795 Ryan et al. Feb 1994 A
5295980 Ersek Mar 1994 A
5296026 Monroe et al. Mar 1994 A
5308342 Sepetka et al. May 1994 A
5322064 Lundquist Jun 1994 A
5322505 Krause et al. Jun 1994 A
5334181 Rubinsky et al. Aug 1994 A
5336699 Cooke et al. Aug 1994 A
5343877 Park Sep 1994 A
5352715 Wallace et al. Oct 1994 A
5356629 Sander Oct 1994 A
5360416 Ausherman et al. Nov 1994 A
5368598 Hasson Nov 1994 A
5372587 Hammerslag et al. Dec 1994 A
5378234 Hammerslag et al. Jan 1995 A
5380307 Chee et al. Jan 1995 A
5385563 Groos Jan 1995 A
5389073 Imran Feb 1995 A
5425770 Piez et al. Jun 1995 A
5431168 Webster, Jr. Jul 1995 A
5431639 Shaw Jul 1995 A
5437636 Snoke et al. Aug 1995 A
5449301 Hanna et al. Sep 1995 A
5449351 Zohmann Sep 1995 A
5458597 Edwards et al. Oct 1995 A
5480382 Hammerslag et al. Jan 1996 A
5484424 Cottenceau et al. Jan 1996 A
5489275 Thompson et al. Feb 1996 A
5496330 Bates et al. Mar 1996 A
5512610 Lin Apr 1996 A
5514130 Baker May 1996 A
5514137 Coutts May 1996 A
5531715 Engelson et al. Jul 1996 A
5535922 Maziarz Jul 1996 A
5549542 Kovalcheck Aug 1996 A
5549679 Kuslich Aug 1996 A
5554114 Wallace et al. Sep 1996 A
5571085 Accisano, III Nov 1996 A
5571088 Lennox Nov 1996 A
5574075 Draemert Nov 1996 A
5599346 Edwards et al. Feb 1997 A
5616121 McKay Apr 1997 A
5620447 Smith et al. Apr 1997 A
5620467 Wagner Apr 1997 A
5624396 McNamara et al. Apr 1997 A
5628771 Mizukawa et al. May 1997 A
5637090 McGee Jun 1997 A
5637091 Hakky et al. Jun 1997 A
5662680 Desai Sep 1997 A
5681282 Eggers et al. Oct 1997 A
5681289 Wilcox et al. Oct 1997 A
5681317 Caldarise Oct 1997 A
5685826 Bonutti Nov 1997 A
5695513 Johnson et al. Dec 1997 A
5697536 Eggers et al. Dec 1997 A
5697909 Eggers et al. Dec 1997 A
5700157 Chung Dec 1997 A
5704926 Sutton Jan 1998 A
5709697 Ratcliff et al. Jan 1998 A
5725568 Hastings Mar 1998 A
5735829 Cherian Apr 1998 A
5741320 Thornton et al. Apr 1998 A
5766153 Eggers et al. Jun 1998 A
5800408 Strauss et al. Sep 1998 A
5810804 Gough Sep 1998 A
5810867 Zarbateny et al. Sep 1998 A
5820592 Hammerslag et al. Oct 1998 A
5833632 Jacobsen et al. Nov 1998 A
5833692 Cesarini et al. Nov 1998 A
5847046 Jiang et al. Dec 1998 A
5849028 Chen Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5855577 Murphy-Chutorian et al. Jan 1999 A
5858003 Atala Jan 1999 A
5860952 Quinn Jan 1999 A
5860974 Abele Jan 1999 A
5876373 Giba et al. Mar 1999 A
5891027 Tu Apr 1999 A
5902251 Vanhooydonk May 1999 A
5902839 Lautenschlager et al. May 1999 A
5914356 Erbe Jun 1999 A
5921956 Grinberg et al. Jul 1999 A
5928239 Mirza Jul 1999 A
5931829 Burbank et al. Aug 1999 A
5944715 Goble et al. Aug 1999 A
5947964 Eggers Sep 1999 A
5972015 Scribner et al. Oct 1999 A
5997581 Khalili Dec 1999 A
6019765 Thornhill et al. Feb 2000 A
6027487 Crocker Feb 2000 A
6030360 Biggs Feb 2000 A
6048346 Reiley et al. Apr 2000 A
6059739 Baumann May 2000 A
6063078 Wittkampf May 2000 A
6064902 Haissaguerre May 2000 A
6066154 Reiley et al. May 2000 A
6066176 Oshida May 2000 A
6073051 Sharkey et al. Jun 2000 A
6080801 Draenert et al. Jun 2000 A
6099514 Sharkey et al. Aug 2000 A
6106524 Eggers et al. Aug 2000 A
6106539 Fortier Aug 2000 A
6110155 Baudino Aug 2000 A
6123702 Swanson Sep 2000 A
6127597 Beyar et al. Oct 2000 A
6135999 Fanton et al. Oct 2000 A
6146355 Biggs Nov 2000 A
6156254 Andrews et al. Dec 2000 A
6183435 Bumbalough et al. Feb 2001 B1
6203507 Wadsworth et al. Mar 2001 B1
6203574 Kawamura Mar 2001 B1
6228052 Pohndorf May 2001 B1
6228904 Yadav et al. May 2001 B1
6231569 Bek et al. May 2001 B1
6231615 Preissman May 2001 B1
6235043 Reiley et al. May 2001 B1
6241734 Scribner et al. Jun 2001 B1
6248110 Reiley et al. Jun 2001 B1
6251092 Qin et al. Jun 2001 B1
6258086 Ashley et al. Jul 2001 B1
6270476 Santoianni et al. Aug 2001 B1
6280413 Clark et al. Aug 2001 B1
6280434 Kinoshita et al. Aug 2001 B1
6280441 Ryan Aug 2001 B1
6280456 Scribner et al. Aug 2001 B1
6280473 Lemperle et al. Aug 2001 B1
6283960 Ashley Sep 2001 B1
6291547 Lyles Sep 2001 B1
6312428 Eggers Nov 2001 B1
6312454 Stockel et al. Nov 2001 B1
6332894 Stalcup et al. Dec 2001 B1
6348055 Preissman Feb 2002 B1
6352533 Ellman et al. Mar 2002 B1
6358251 Mirza Mar 2002 B1
6375659 Erbe et al. Apr 2002 B1
6383188 Kuslich et al. May 2002 B2
6383190 Preissman May 2002 B1
6395007 Bhatnagar et al. May 2002 B1
6408889 Komachi Jun 2002 B1
6409722 Hoey et al. Jun 2002 B1
6428894 Babich et al. Aug 2002 B1
6437019 Rusin et al. Aug 2002 B1
6440138 Reiley et al. Aug 2002 B1
6447506 Swanson et al. Sep 2002 B1
6447514 Stalcup et al. Sep 2002 B1
6464683 Samuelson et al. Oct 2002 B1
6478793 Cosman et al. Nov 2002 B1
6479565 Stanley Nov 2002 B1
6484904 Horner et al. Nov 2002 B1
6506217 Arnett Jan 2003 B1
6511471 Rosenman et al. Jan 2003 B2
6524296 Beals Feb 2003 B1
6565588 Clement et al. May 2003 B1
6575969 Rittman et al. Jun 2003 B1
6575978 Peterson et al. Jun 2003 B2
6576249 Gendler et al. Jun 2003 B1
6582446 Marchosky Jun 2003 B1
6592559 Pakter et al. Jul 2003 B1
6599961 Pienkowski et al. Jul 2003 B1
6620162 Kuslich et al. Jul 2003 B2
6602248 Sharps et al. Aug 2003 B1
6607544 Boucher et al. Aug 2003 B1
6613054 Scribner et al. Sep 2003 B2
6622731 Daniel Sep 2003 B2
6623448 Slater Sep 2003 B2
6638268 Naizi Oct 2003 B2
6663647 Reiley et al. Oct 2003 B2
6641587 Scribner et al. Nov 2003 B2
6645213 Sand et al. Nov 2003 B2
6676665 Foley et al. Jan 2004 B2
6679886 Weikel et al. Jan 2004 B2
6689823 Bellare et al. Feb 2004 B1
6692532 Healy et al. Feb 2004 B1
6716216 Boucher et al. Apr 2004 B1
6719761 Reiley et al. Apr 2004 B1
6719773 Boucher et al. Apr 2004 B1
6726691 Osorio et al. Apr 2004 B2
6730095 Olson, Jr. et al. May 2004 B2
6740090 Cragg et al. May 2004 B1
6740093 Hochschuler et al. May 2004 B2
6743239 Kuehn et al. Jun 2004 B1
6746451 Middleton et al. Jun 2004 B2
6752863 Lyles et al. Jun 2004 B2
6753007 Haggard et al. Jun 2004 B2
6770079 Bhatnagar et al. Aug 2004 B2
6814734 Chappuis et al. Nov 2004 B2
6814736 Reiley et al. Nov 2004 B2
6818001 Wulfman et al. Nov 2004 B2
6832984 Stelzer et al. Dec 2004 B2
6835193 Epstein et al. Dec 2004 B2
6837867 Kortelling Jan 2005 B2
6863672 Reiley et al. Mar 2005 B2
6869430 Balbierz et al. Mar 2005 B2
6869445 Johnson Mar 2005 B1
6875219 Arramon Apr 2005 B2
6881214 Cosman et al. Apr 2005 B2
6887246 Bhatnagar et al. May 2005 B2
6899715 Beaty May 2005 B1
6899719 Reiley et al. May 2005 B2
6907884 Pellegrino et al. Jun 2005 B2
6913594 Coleman et al. Jul 2005 B2
6916306 Jenkins et al. Jul 2005 B1
6923813 Phillips Aug 2005 B2
6945956 Waldhauser et al. Sep 2005 B2
6953594 Lee et al. Oct 2005 B2
6955716 Xu et al. Oct 2005 B2
6976987 Flores Dec 2005 B2
6979312 Shimada Dec 2005 B2
6979352 Reynolds Dec 2005 B2
6981981 Reiley et al. Jan 2006 B2
6991616 Bencini et al. Jan 2006 B2
6998128 Haggard et al. Feb 2006 B2
7004930 Marshall Feb 2006 B2
7004945 Boyd et al. Mar 2006 B2
7008433 Voellmicke et al. Mar 2006 B2
7018460 Xu et al. Mar 2006 B2
7022133 Yee et al. Apr 2006 B2
7029468 Honebrink Apr 2006 B2
7044954 Reiley et al. May 2006 B2
7059330 Makower et al. Jun 2006 B1
7063682 Whayne et al. Jun 2006 B1
7066942 Treace Jun 2006 B2
RE39196 Ying et al. Jul 2006 E
7081122 Reiley et al. Jul 2006 B1
7081161 Genge et al. Jul 2006 B2
7091258 Neubert et al. Aug 2006 B2
7091260 Kūhn Aug 2006 B2
7094202 Nobis et al. Aug 2006 B2
7094286 Liu Aug 2006 B2
7108696 Daniel et al. Sep 2006 B2
7109254 Müller et al. Sep 2006 B2
7112205 Carrison Sep 2006 B2
7114501 Johnson et al. Oct 2006 B2
7138442 Smith et al. Nov 2006 B2
7153306 Ralph et al. Dec 2006 B2
7153307 Scribner et al. Dec 2006 B2
7156843 Skarda Jan 2007 B2
7156845 Mulier Jan 2007 B2
7160296 Pearson et al. Jan 2007 B2
7166121 Reiley et al. Jan 2007 B2
7172629 McKay et al. Feb 2007 B2
7179255 Lettice et al. Feb 2007 B2
7186234 Dahla et al. Mar 2007 B2
7186761 Soffiati et al. Mar 2007 B2
7226481 Kuslich et al. Jun 2007 B2
7252671 Scribner et al. Aug 2007 B2
7267683 Sharkey et al. Sep 2007 B2
7270661 Dahla et al. Sep 2007 B2
7294127 Leung Nov 2007 B2
7465318 Sennett et al. Dec 2008 B2
7480533 Cosman et al. Jan 2009 B2
7503920 Siegal Mar 2009 B2
7544196 Bagga et al. Jun 2009 B2
7559932 Truckai et al. Jul 2009 B2
7569054 Michelson Aug 2009 B2
7572263 Preissman Aug 2009 B2
7591822 Olson, Jr. et al. Sep 2009 B2
7595634 Flandre et al. Sep 2009 B2
7625364 Corcoran et al. Dec 2009 B2
7641664 Pagano Jan 2010 B2
7731720 Sand et al. Jun 2010 B2
7811291 Liu et al. Oct 2010 B2
7824403 Vaska Nov 2010 B2
7842041 Liu et al. Nov 2010 B2
7887543 Sand et al. Feb 2011 B2
7905884 Simonton et al. Mar 2011 B2
7918874 Siegal Apr 2011 B2
7972340 Sand et al. Jul 2011 B2
7976542 Cosman Jul 2011 B1
8034071 Scribner et al. Oct 2011 B2
8246627 Vanleeuwen et al. Aug 2012 B2
8284128 Kimura Oct 2012 B2
8518036 Leung Aug 2013 B2
8583260 Knudson Nov 2013 B2
8591507 Kramer et al. Nov 2013 B2
8663226 Germain Mar 2014 B2
RE44883 Cha May 2014 E
8758349 Germain et al. Jun 2014 B2
8827981 Liu et al. Sep 2014 B2
8864760 Kramer et al. Oct 2014 B2
8936631 Nguyen Jan 2015 B2
9113974 Germain Aug 2015 B2
9125671 Germain et al. Sep 2015 B2
9161809 Germain et al. Oct 2015 B2
9421057 Germain Aug 2016 B2
9743938 Germain et al. Aug 2017 B2
20010011174 Reiley et al. Aug 2001 A1
20010023349 Van Tassel et al. Sep 2001 A1
20020007180 Wittenberger et al. Jan 2002 A1
20020013600 Scribner et al. Jan 2002 A1
20020026195 Layne et al. Feb 2002 A1
20020026197 Foley et al. Feb 2002 A1
20020068929 Zvuloni Jun 2002 A1
20020068974 Kuslich et al. Jun 2002 A1
20020077595 Hundertmark et al. Jun 2002 A1
20020082605 Reiley et al. Jun 2002 A1
20020115742 Trieu et al. Aug 2002 A1
20020128638 Chauvel et al. Sep 2002 A1
20020133148 Daniel et al. Sep 2002 A1
20020156483 Voellmicke et al. Oct 2002 A1
20020188299 Reiley et al. Dec 2002 A1
20020188300 Arramon et al. Dec 2002 A1
20030014094 Hammack et al. Jan 2003 A1
20030032929 McGuckin Feb 2003 A1
20030036763 Bhatnagar et al. Feb 2003 A1
20030043963 Yamagami et al. Mar 2003 A1
20030050644 Boucher et al. Mar 2003 A1
20030069522 Jasobsen et al. Apr 2003 A1
20030073979 Naimark et al. Apr 2003 A1
20030130664 Boucher et al. Jul 2003 A1
20030163085 Tanner et al. Aug 2003 A1
20030171744 Leung et al. Sep 2003 A1
20030191489 Reiley et al. Oct 2003 A1
20030195547 Scribner et al. Oct 2003 A1
20030212394 Pearson et al. Nov 2003 A1
20030212395 Woloszko et al. Nov 2003 A1
20030220414 Axen et al. Nov 2003 A1
20030225432 Baptiste et al. Dec 2003 A1
20030233096 Osorio et al. Dec 2003 A1
20040023384 Fukaya Feb 2004 A1
20040023784 Yu et al. Feb 2004 A1
20040024081 Trieu et al. Feb 2004 A1
20040024398 Hovda et al. Feb 2004 A1
20040024409 Sand et al. Feb 2004 A1
20040024410 Olson et al. Feb 2004 A1
20040034384 Fukaya Feb 2004 A1
20040044096 Smith et al. Mar 2004 A1
20040044350 Martin et al. Mar 2004 A1
20040059328 Daniel et al. Mar 2004 A1
20040087936 Stern et al. May 2004 A1
20040087994 Suddaby May 2004 A1
20040092946 Bagga et al. May 2004 A1
20040097612 Rosenberg et al. May 2004 A1
20040111136 Sharkey et al. Jun 2004 A1
20040127987 Evans et al. Jul 2004 A1
20040133208 Weikel et al. Jul 2004 A1
20040138758 Evans et al. Jul 2004 A1
20040153064 Foley et al. Aug 2004 A1
20040153115 Reiley et al. Aug 2004 A1
20040158237 Abboud et al. Aug 2004 A1
20040167561 Boucher et al. Aug 2004 A1
20040167562 Osorio et al. Aug 2004 A1
20040167625 Beyar et al. Aug 2004 A1
20040210231 Broucher et al. Oct 2004 A1
20040215343 Hochschuler et al. Oct 2004 A1
20040220577 Cragg Nov 2004 A1
20040220680 Yamamoto et al. Nov 2004 A1
20040225296 Reiss et al. Nov 2004 A1
20040226479 Lyles et al. Nov 2004 A1
20040230309 DiMauro et al. Nov 2004 A1
20040236186 Chu Nov 2004 A1
20040247644 Bratt et al. Dec 2004 A1
20040267271 Scribner et al. Dec 2004 A9
20050027245 Sachdeva et al. Feb 2005 A1
20050033303 Chappuis et al. Feb 2005 A1
20050038383 Kelley et al. Feb 2005 A1
20050038422 Maurice Feb 2005 A1
20050043737 Reiley et al. Feb 2005 A1
20050055030 Falahee Mar 2005 A1
20050060030 Lashinski et al. Mar 2005 A1
20050070844 Chow et al. Mar 2005 A1
20050070912 Voellmicke Mar 2005 A1
20050070915 Mazzuca et al. Mar 2005 A1
20050090852 Layne et al. Apr 2005 A1
20050113836 Lozier et al. May 2005 A1
20050119650 Sanders et al. Jun 2005 A1
20050124989 Suddaby Jun 2005 A1
20050143827 Globerman et al. Jun 2005 A1
20050177168 Brunnett et al. Aug 2005 A1
20050177210 Lueng et al. Aug 2005 A1
20050182412 Johnson et al. Aug 2005 A1
20050182413 Johnson et al. Aug 2005 A1
20050187556 Stack et al. Aug 2005 A1
20050199156 Khairoun et al. Sep 2005 A1
20050209557 Carroll et al. Sep 2005 A1
20050216018 Sennett Sep 2005 A1
20050228391 Levy et al. Oct 2005 A1
20050234425 Miller et al. Oct 2005 A1
20050240193 Layne et al. Oct 2005 A1
20050251267 Winterbottom et al. Oct 2005 A1
20050251266 Maspero et al. Nov 2005 A1
20050261683 Veldhuizen et al. Nov 2005 A1
20050283148 Janssen Dec 2005 A1
20050287771 Seamons et al. Dec 2005 A1
20060024348 Engqvist et al. Feb 2006 A1
20060025763 Nelson et al. Feb 2006 A1
20060041033 Bisig et al. Feb 2006 A1
20060052743 Reynolds Mar 2006 A1
20060064101 Arramon Mar 2006 A1
20060074433 McGill et al. Apr 2006 A1
20060084977 Lieberman Apr 2006 A1
20060085009 Truckai et al. Apr 2006 A1
20060100635 Reiley et al. May 2006 A1
20060100706 Shadduck et al. May 2006 A1
20060106392 Embry May 2006 A1
20060106459 Truckai et al. May 2006 A1
20060116689 Albans et al. Jun 2006 A1
20060116690 Pagano Jun 2006 A1
20060122623 Truckai et al. Jun 2006 A1
20060142732 Karmarkar et al. Jun 2006 A1
20060149268 Truckai et al. Jul 2006 A1
20060149281 Reiley et al. Jul 2006 A1
20060156959 Engqvist et al. Jul 2006 A1
20060184106 McDaniel et al. Aug 2006 A1
20060184192 Markworth et al. Aug 2006 A1
20060200121 Mowery Sep 2006 A1
20060206116 Yeung Sep 2006 A1
20060206136 Sachdeva et al. Sep 2006 A1
20060217704 Cockburn et al. Sep 2006 A1
20060217736 Kaneko Sep 2006 A1
20060229625 Truckai et al. Oct 2006 A1
20060229631 Reiley et al. Oct 2006 A1
20060235417 Sala Oct 2006 A1
20060259023 Abboud et al. Nov 2006 A1
20060264819 Fischer et al. Nov 2006 A1
20060264945 Edidin et al. Nov 2006 A1
20060266372 Miller et al. Nov 2006 A1
20060270750 Almen et al. Nov 2006 A1
20060271061 Beyar et al. Nov 2006 A1
20060276797 Botimer Dec 2006 A1
20060276819 Osorio et al. Dec 2006 A1
20060293687 Bogert Dec 2006 A1
20070006692 Phan Jan 2007 A1
20070010845 Gong et al. Jan 2007 A1
20070016130 Leeflang et al. Jan 2007 A1
20070016211 Botimer Jan 2007 A1
20070021769 Scribner et al. Jan 2007 A1
20070043373 Sala Feb 2007 A1
20070055201 Seto et al. Mar 2007 A1
20070055260 Cragg Mar 2007 A1
20070055266 Osorio et al. Mar 2007 A1
20070055275 Schaller Mar 2007 A1
20070055277 Osorio et al. Mar 2007 A1
20070055278 Osorio et al. Mar 2007 A1
20070055279 Sand et al. Mar 2007 A1
20070055281 Osorio et al. Mar 2007 A1
20070055283 Scribner Mar 2007 A1
20070055284 Osorio Mar 2007 A1
20070055285 Osorio et al. Mar 2007 A1
20070055300 Osorio et al. Mar 2007 A1
20070055382 Osorio et al. Mar 2007 A1
20070059281 Moseley et al. Mar 2007 A1
20070067034 Chirico et al. Mar 2007 A1
20070093840 Pacelli Apr 2007 A1
20070114248 Kovac May 2007 A1
20070118142 Krueger et al. May 2007 A1
20070118143 Ralph et al. May 2007 A1
20070142842 Krueger et al. Jun 2007 A1
20070156130 Thistle Jul 2007 A1
20070162042 Dunker Jul 2007 A1
20070173939 Kim et al. Jul 2007 A1
20070185231 Liu et al. Aug 2007 A1
20070197935 Reiley Aug 2007 A1
20070198023 Sand et al. Aug 2007 A1
20070203500 Gordon Aug 2007 A1
20070211563 DeVries Sep 2007 A1
20070233146 Henniges et al. Oct 2007 A1
20070260223 Scheibe et al. Nov 2007 A1
20070260257 Phan Nov 2007 A1
20070270876 Kuo et al. Nov 2007 A1
20070276319 Betts Nov 2007 A1
20070282305 Goldfarb et al. Dec 2007 A1
20080004615 Woloszko Jan 2008 A1
20080033422 Turner et al. Feb 2008 A1
20080058725 Scribner et al. Mar 2008 A1
20080058821 Maurer et al. Mar 2008 A1
20080058827 Osorio et al. Mar 2008 A1
20080058840 Albrecht Mar 2008 A1
20080065020 Ralph et al. Mar 2008 A1
20080065087 Osorio et al. Mar 2008 A1
20080065190 Osorio et al. Mar 2008 A1
20080086142 Kohm et al. Apr 2008 A1
20080140079 Osorio et al. Jun 2008 A1
20080183165 Buysee et al. Jul 2008 A1
20080183265 Bly Jul 2008 A1
20080195112 Liu et al. Aug 2008 A1
20080208255 Siegal Aug 2008 A1
20080221608 Betts Sep 2008 A1
20080228192 Beyer et al. Sep 2008 A1
20080249481 Crainich Oct 2008 A1
20080249525 Lee et al. Oct 2008 A1
20080255571 Truckai et al. Oct 2008 A1
20080269766 Justis Oct 2008 A1
20080269796 Reiley et al. Oct 2008 A1
20080287741 Ostrovsky et al. Nov 2008 A1
20080294167 Schumacher et al. Nov 2008 A1
20090076517 Reiley et al. Mar 2009 A1
20090105775 Mitchell et al. Apr 2009 A1
20090131867 Liu et al. May 2009 A1
20090131886 Liu et al. May 2009 A1
20090131945 Liu et al. May 2009 A1
20090131948 Liu May 2009 A1
20090131950 Liu et al. May 2009 A1
20090131986 Lee May 2009 A1
20090182427 Liu et al. Jul 2009 A1
20090198243 Melsheimer Aug 2009 A1
20090264862 Neidert et al. Oct 2009 A1
20090264892 Beyar et al. Oct 2009 A1
20090292289 Sand et al. Nov 2009 A9
20090293687 Nino et al. Dec 2009 A1
20090299282 Lau et al. Dec 2009 A1
20100057087 Cha Mar 2010 A1
20100082033 Germain Apr 2010 A1
20100114184 Degtyar May 2010 A1
20100121332 Crainich et al. May 2010 A1
20100152724 Marion et al. Jun 2010 A1
20100160922 Liu et al. Jun 2010 A1
20100211076 Germain et al. Aug 2010 A1
20100274270 Patel Oct 2010 A1
20100298832 Lau et al. Nov 2010 A1
20110034884 Pellegrino et al. Feb 2011 A9
20110098701 McIntyre et al. Apr 2011 A1
20110160737 Steffen et al. Jun 2011 A1
20110251615 Truckai et al. Oct 2011 A1
20110295261 Germain Dec 2011 A1
20110295262 Germain et al. Dec 2011 A1
20110301590 Podhajsky et al. Dec 2011 A1
20120065543 Ireland Mar 2012 A1
20120130381 Germain May 2012 A1
20120158004 Burger et al. Jun 2012 A1
20120191095 Burger et al. Jul 2012 A1
20120239049 Truckai Sep 2012 A1
20120265186 Burger et al. Oct 2012 A1
20120277730 Salahieh Nov 2012 A1
20120330180 Pellegrino et al. Dec 2012 A1
20120330301 Pellegrino et al. Dec 2012 A1
20130006232 Pellegrino Jan 2013 A1
20130072941 Tan-Malecki et al. Mar 2013 A1
20130041377 Kuntz Apr 2013 A1
20130231654 Germain Sep 2013 A1
20130237795 Carr Sep 2013 A1
20130261615 Kramer et al. Oct 2013 A1
20130261621 Kramer et al. Oct 2013 A1
20130345709 Burger et al. Dec 2013 A1
20140135779 Germain May 2014 A1
20140163566 Phan et al. Jun 2014 A1
20140316413 Burger et al. Oct 2014 A1
20140350542 Kramer et al. Nov 2014 A1
20140371740 Germain et al. Dec 2014 A1
20150216594 Prakash Aug 2015 A1
20150297246 Patel et al. Oct 2015 A1
20150313614 Germain Nov 2015 A1
20160228131 Brockman et al. Aug 2016 A1
20170095291 Harrington Apr 2017 A1
Foreign Referenced Citations (32)
Number Date Country
2785207 Jul 2011 CA
88203061 Nov 1988 CN
2841051 Nov 2006 CN
1459691 Sep 2004 EP
2004242936 Sep 2004 JP
2008510530 Apr 2008 JP
2008528081 Jul 2008 JP
2008541878 Nov 2008 JP
2010063887 Mar 2010 JP
2011500156 Jan 2011 JP
1993004634 Mar 1993 WO
1996013297 May 1996 WO
1996020752 Jul 1996 WO
1997003611 Feb 1997 WO
2002003870 Jan 2002 WO
2003101308 Dec 2003 WO
2005122938 Dec 2005 WO
2007036815 Apr 2007 WO
2007087400 Aug 2007 WO
2008076330 Jun 2008 WO
2008084479 Jul 2008 WO
2010039894 Apr 2010 WO
2010081187 Jul 2010 WO
2010135602 Nov 2010 WO
2010135606 Nov 2010 WO
2011066465 Jun 2011 WO
2011114602 Sep 2011 WO
2011137357 Nov 2011 WO
2011137377 Nov 2011 WO
2012071464 May 2012 WO
2013147990 Oct 2013 WO
2014093673 Jun 2014 WO
Non-Patent Literature Citations (80)
Entry
US 7,063,700 B2, 06/2006, Michelson (withdrawn)
International Search Report and Written Opinion dated Jul. 26, 2011 for PCT/US2011/034628.
Notice of Allowance dated May 3, 2017 for U.S. Appl. No. 14/815,620.
Notice of Allowance dated May 26, 2015 for U.S. Appl. No. 13/098,116.
Office Action dated Jan. 18, 2017 for U.S. Appl. No. 14/815,620.
Office Action dated May 21, 2014 for U.S. Appl. No. 13/098,116.
Office Action dated May 31, 2016 for U.S. Appl. No. 14/815,620.
Office Action dated Jul. 29, 2013 for U.S. Appl. No. 13/098,116.
Notice of Allowance dated Aug. 8, 2019 for U.S. Appl. No. 15/836,125.
Notice of Allowance dated Aug. 9, 2019 for U.S. Appl. No. 15/836,241.
Park, et al.,The Materials Properties of Bone-Particle Impregnated PMMA, Journal of Biomedical Engineering, vol. 108 ,1986 ,141-148.
Park, et al.,Biomaterials: An Introduction—Second Edition, Plenum Press ,1992 ,177-178.
Office Action dated Jun. 25, 2015 for U.S. Appl. No. 13/853,397.
Office Action dated Jul. 11, 2017 for U.S. Appl. No. 14/815,812.
Office Action dated Jul. 12, 2017 for U.S. Appl. No. 13/083,411.
Office Action dated Jul. 30, 2013 for U.S. Appl. No. 13/083,411.
Office Action dated Sep. 6, 2017 for U.S. Appl. No. 15/211,359.
Office Action dated Sep. 26, 2017 for U.S. Appl. No. 15/388,598.
Office Action dated Nov. 12, 2013 for U.S. Appl. No. 13/083,411.
Office Action dated Nov. 25, 2016 for U.S. Appl. No. 13/083,411.
Office Action dated Dec. 3, 2012 for U.S. Appl. No. 12/571,174.
Office Action dated Feb. 27, 2013 for U.S. Appl. No. 12/578,455.
Office Action dated Sep. 10, 2013 for U.S. Appl. No. 12/571,174.
Disc-O-Tech confidence Cement System at http://www.disc-o-tech.com/Articles/Article.asp?CategoryID=4&ArticleID=168 accessed, , Dec. 3, 2007.
Dai, et al., Bone-Particle-Impregnated Bone Cement: an in vivo weight-bearing study, Journal Biomedical Materials Search, vol. 25 ,191 ,141-156.
Hasenwinkel, et al.,“A Novel High-Viscosity, Two-Solution Acrylic Bone Cement: Effect of Chemical Composition on Properties”, J. Biomed Mater. Res. vol. 47, No. 1 ,1999 ,36-45.
Klawitter, et al.,Application of Porous Ceramics for the Attachment of Load Bearing Internal Orthopedic Applications, J. Biomed. Mater. Res. Symp., 2(1) ,1972 ,61-229.
Liu, et al.,Bone-Particle-Impregnanted Bone Cement: An In Vitro Study, Journal of Biomedical Materials Research, vol. 21 ,1987 ,247-261.
Office Action dated May 24, 2012 for U.S. Appl. No. 12/578,455.
Office Action dated May 17, 2010 for U.S. Appl. No. 12/261,987.
European Examination Report dated Dec. 19, 2017 for EP13767383.6.
European Search Report dated Jan. 7, 2019 for EP16793433.0.
European Search Report dated Jun. 8, 2017 for EP17154660.9.
European Search Report dated Nov. 15, 2017 for EP09818476.5.
European Search Report dated Nov. 16, 2016 for EP14772615.2.
International Search Report and Written Opinion dated Jan. 9, 2012 for PCT/US2011/034185.
International Search Report and Written Opinion dated Jan. 22, 2009 for PCT/US2008/83698.
International Search Report and Written Opinion dated Feb. 7, 2018 for PCT/US2017/058303.
International Search Report and Written Opinion dated Feb. 21, 2018 for PCT/US2017/063281.
International Search Report and Written Opinion dated Mar. 30, 2018 for PCT/US2017/065328.
International Search Report and Written Opinion dated Apr. 23, 2016 for PCT/US2018/012372.
International Search Report and Written Opinion dated Jul. 20, 2010 for PCT/US2010/035687.
International Search Report and Written Opinion dated Aug. 25, 2009 for PCT/US2009/035726.
International Search Report and Written Opinion dated Nov. 20, 2009 for PCT/US2009/059113.
Notice of Allowance dated Jan. 4, 2017 for U.S. Appl. No. 13/302,927.
Notice of Allowance dated Jan. 18, 2017 for U.S. Appl. No. 13/097,998.
Notice of Allowance dated Feb. 21, 2019 for U.S. Appl. No. 14/139,372.
Notice of Allowance dated Apr. 3, 2019 for U.S. Appl. No. 15/349,715.
Notice of Allowance dated Apr. 9, 2014 for U.S. Appl. No. 12/578,455.
Notice of Allowance dated Apr. 23, 2018 for U.S. Appl. No. 13/083,411.
Notice of Allowance dated May 11, 2018 for U.S. Appl. No. 14/453,427.
Notice of Allowance dated Aug. 24, 2018 for U.S. Appl. No. 15/388,598.
Notice of Allowance dated Oct. 28, 2016 for U.S. Appl. No. 13/853,397.
Notice of Allowance dated Nov. 8, 2013 for U.S. Appl. No. 12/578,455.
Notice of Allowance dated Nov. 9, 2017 for U.S. Appl. No. 14/815,812.
Notice of Allowance dated Nov. 18, 2016 for U.S. Appl. No. 13/097,998.
Notice of Allowance dated Nov. 25, 2013 for U.S. Appl. No. 12/571,174.
Notice of Allowance dated Nov. 25, 2016 for U.S. Appl. No. 13/853,397.
Notice of Allowance dated Dec. 13, 2018 for U.S. Appl. No. 15/917,454.
Notice of Allowance dated Dec. 28, 2017 for U.S. Appl. No. 15/211,359.
Notice of Allowance dated Aug. 31, 2016 for U.S. Appl. No. 14/887,007.
Office Action dated Jan. 26, 2011 for U.S. Appl. No. 11/941,764.
Office Action dated Jan. 26, 2017 for U.S. Appl. No. 14/815,812.
Office Action dated Feb. 3, 2016 for U.S. Appl. No. 13/853,397.
Office Action dated Feb. 10, 2015 for U.S. Appl. No. 13/083,411.
Office Action dated Feb. 23, 2010 for U.S. Appl. No. 11/941,733.
Office Action dated Feb. 23, 2010 for U.S. Appl. No. 11/941,764.
Office Action dated Mar. 1, 2017 for U.S. Appl. No. 15/211,359.
Office Action dated Mar. 21, 2011 for U.S. Appl. No. 11/941,764.
Office Action dated Mar. 21, 2011 for U.S. Appl. No. 12/029,428.
Office Action dated Apr. 19, 2018 for U.S. Appl. No. 15/388,598.
Office Action dated Apr. 24, 2017 for U.S. Appl. No. 14/453,427.
Office Action dated Apr. 26, 2010 for U.S. Appl. No. 12/029,428.
Office Action dated May 1, 2009 for U.S. Appl. No. 12/261,987.
Office Action dated May 5, 2010 for U.S. Appl. No. 11/941,764.
Office Action dated May 13, 2009 for U.S. Appl. No. 12/029,428.
Office Action dated Jun. 4, 2018 for U.S. Appl. No. 15/349,715.
Office Action dated Jun. 8, 2009 for U.S. Appl. No. 11/941,764.
Office Action dated Dec. 20, 2019 for U.S. Appl. No. 15/862,441.
Office Action dated Dec. 26, 2019 for U.S. Appl. No. 15/822,864.
Related Publications (1)
Number Date Country
20180028199 A1 Feb 2018 US
Provisional Applications (1)
Number Date Country
61329394 Apr 2010 US
Continuations (2)
Number Date Country
Parent 14815620 Jul 2015 US
Child 15675315 US
Parent 13098116 Apr 2011 US
Child 14815620 US